CBD and Your Health

After many years of prohibition, governments across the world have started changing their policies on marijuana. One of the main reasons for this that studies have proven that cannabis has medicinal properties. There have been many studies into cannabis which show that this plant can change the face of medicine as we know it.

In the United States, many states have made the medicinal use of cannabis legal. The government recently passed a bill that legalized the growing of industrial hemp legal across all 50 states. However, each state has its laws about how the process should go. The 2018 Farm Bill also made the use of CBD legal at the federal level.

The Food and Drug Administration (FDA) has supported the use of hemp as medicine. However, health authorities say there is a need for more studies into how cannabis products are used in foods. The FDA recently approved a cannabis-based medicine; which is the first in US history. GW Pharmaceuticals produced the drug called Epidiolex. Epidiolex is meant for the treatment of seizures which affects children suffering from two rare forms of epilepsy – Dravet syndrome and Lennox-Gastaut syndrome. These forms of epilepsy trigger severe seizures that can be fatal.

Epidiolex is produced with Cannabidiol or CBD which is a cannabinoid in the cannabis plant. CBD is typically extracted from the hemp plant. Studies show that CBD is very potent when used as medicine and it can treat a wide range of diseases. There have been many clinical studies which show that can provide relief for conditions such as anxiety, chronic pain, and movement disorders. CBD has also been shown to treat insomnia, Parkinson’s disease, inflammation and Post Traumatic stress disorder (PTSD).

“This approval serves as a reminder that advancing that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. And, the FDA is committed to this kind of careful scientific research and drug development,” the FDA Commissioner Scott Gottlieb, M.D. “Controlled clinical trials testing the safety and efficacy of a drug, along with careful review through the FDA’s drug approval process, is the most appropriate way to bring marijuana-derived treatments to patients. Because of the adequate and well-controlled clinical studies that supported this approval, prescribers can have confidence in the drug’s uniform strength and consistent delivery that support appropriate dosing needed for treating patients with these complex and serious epilepsy syndromes. We’ll continue to support rigorous scientific research on the potential medical uses of marijuana-derived products and work with product developers who are interested in bringing patients safe and effective, high-quality products. But at the same time, we are prepared to take action when we see the illegal marketing of CBD-containing products with serious, unproven medical claims. Marketing unapproved products, with uncertain dosage and formulations, can keep patients from accessing appropriate, recognized therapies to treat serious and even fatal disease.”